- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06606262
Tonsillektomi versus tonsillotomi i behandling av tilbakevendende akutt tonsillitt
Tonsillektomi versus tonsillotomi i behandling av tilbakevendende akutt tonsillitt: En randomisert kontrollert ikke-inferioritetsforsøk
Background: recurrent acute tonsillitis (RT) is a frequent condition affecting teenagers and adults. Patients suffer from recurring throat symptoms, fever and impaired quality of life (QOL). Tonsillectomy (TE) is the only well-known treatment, but studies indicate that tonsillotomy (TO) is associated with less morbidity (eg. pain and bleeding) and equal efficiency (e.g. reduced number of sore throat episodes and improved QOL). The investigator aim to clarify whether TO is a non-inferior alternative to TE.
Methods: inclusion and randomization of 250 adult RT patients for TE or TO with a 12 month follow up. Comparisons will be made between groups, and outcome measures includes number of sore throat episodes, QOL and postoperative pain.
Discussion: the study has the potential to improve the treatment of a prevalent disease by enhancing knowledge of an alternative procedure (TO) associated with less discomfort and risk than the current standard procedure (TE) and a presumably low risk of insufficiency.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Aalborg, Danmark, 9000
- Aalborg University Hospital
-
Aarhus, Danmark, 8200
- Aarhus University Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Adults (age ≥15 years) with RT, defined as a minimum of five tonsillitis episodes in one year or a minimum of three tonsillitis episodes per year for two years (Danish National Guidelines criteria
- The ability to understand Danish orally and in writing.
Exclusion Criteria:
- Previous TE or TO.
- Suspected tonsillar malignancy.
- History of malignant tumor in the oral cavity, the pharynx or the larynx.
- Previous radiation therapy on head or neck.
- Hemorrhagic diathesis or anticoagulant therapy.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Tonsillotomy
A potential non-inferior surgical procedure for treating recurrent acute tonsillitis. |
Bilateral partial removal of the palatine tonsils to a level between the pharyngeal pillars and the tonsillar capsule. Surgery will be performed under general anesthesia using monopolar electrocautery.
Andre navn:
|
|
Aktiv komparator: Tonsillectomy
The current standard surgical procedure for treating recurrent acute tonsillitis. |
Bilateral extracapsular removal of palatine tonsils. Surgery will be performed under general anesthesia using "cold knife" dissection.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Antall sår hals-episoder etter TE vs. TO.
Tidsramme: 12 måneder (og 24, 36 og 60 måneder)
|
12 måneder (og 24, 36 og 60 måneder)
|
|
|
QOL measured as postoperative Tonsillectomy Outcome Inventory 14 (TOI-14) score after TE vs. TO
Tidsramme: 12 months (and 24, 36 and 60 months)
|
A disease-specific questionnaire for adults with tonsillitis. It is used pre- and postoperatively to detect changes in quality of life. It consists of 14 questions that covers four subscales: throat dis-comfort (question 1-4) general health (question 5-6), resources (question 7-10), and social psychological restrictions (question 11-14). The questionnaire uses a six-point Likert scale with 0 representing "no problem" and 5 representing "couldn't be worse". The points are summed, divided by the number of questions multiplied by 5, and multiplied by 100, giving scores in the range 0-100, where higher scores reflect poorer quality of life |
12 months (and 24, 36 and 60 months)
|
|
Summarized postoperative pain scores (days 1-10)
Tidsramme: Days 1-10
|
Measured on a numeric rating scale from 0 til 10 in which 0 represents "no pain" and 10 represents "excruciating pain" |
Days 1-10
|
|
Overall postoperative discomfort (day 21)
Tidsramme: Day 21
|
Measured on a numeric rating scale from 0 til 10 in which 0 represents "no discomfort" and 10 represents "excruciating discomfort" |
Day 21
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Andel pasienter helbredet (definert som postoperativ TOI-14<15) etter TE vs.
Tidsramme: 12 måneder (og 24, 36 og 60 måneder)
|
12 måneder (og 24, 36 og 60 måneder)
|
|
|
Antall sår hals dager etter TE vs. TO
Tidsramme: 12 måneder (og 24, 36 og 60 måneder)
|
12 måneder (og 24, 36 og 60 måneder)
|
|
|
Prevalens av reoperasjon etter TE vs. TO
Tidsramme: 12 måneder (og 24, 36 og 60 måneder)
|
12 måneder (og 24, 36 og 60 måneder)
|
|
|
Overall patient satisfaction after TE vs. TO
Tidsramme: 12 months (and 24, 36 and 60 months)
|
Patients will be asked the following question: "Keeping in mind your full experience and the effects of surgery so far, are you satisfied with having undergone surgery?. Possible answers are 1) "yes", 2) "no" and 3) "I don't know" |
12 months (and 24, 36 and 60 months)
|
|
Postoperative Glasgow Benefit Inventory (GBI) score after TE vs. TO
Tidsramme: 12 months (and 24, 36 and 60 months)
|
A generic questionnaire for otorhinolaryngological interventions. It is used post-intervention to detect changes in quality of life. It consists of 18 questions that covers three subscales: a general health sub-scale (question 1-6, 9-10, 14, 16-18), a social support subscale (question 7, 11 and 15) and a physical health subscale (question 8, 12-13). The questionnaire uses a five-point Likert scale with 1 representing "worst change of health status" and 5 representing "best change of health status". The points are summed and divided by the number of questions (resulting in average scores), and by subtracting 3 and multiplying by 50, the final scores range from -100 to +100. 0 indicates no change, higher scores reflect better quality of life |
12 months (and 24, 36 and 60 months)
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- TETO study protocol
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .